James N. Jarvis
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research 41
- Immunology top 5%
- Reproductive System and Pregnancy 9
- Immunodeficiency and Autoimmune Disorders 9
- Speech and Hearing top 1%
- Adolescent and Pediatric Healthcare 17
- Rheumatology top 2%
- Systemic Lupus Erythematosus Research 14
- Rheumatoid Arthritis Research and Therapies 12
-
- Childhood Cancer Survivors' Quality of Life 12
-
- Lymphoma Diagnosis and Treatment 11
- Co-authors
- Kaiyu JiangYanmin ChenMark Barton FrankMichael CentolaJohn M. ChaneyLarry L. MullinsIgor DozmorovPéter Szodoray
- Partner nations
- United StatesJapanIndia
In The Last Decade
James N. Jarvis
112 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 124
- Hematology 597
- Immunology 752
- Speech and Hearing 231
- Rheumatology 464
- Pediatrics, Perinatology and Child Health 219
Countries citing papers authored by James N. Jarvis
This map shows the geographic impact of James N. Jarvis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James N. Jarvis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James N. Jarvis more than expected).
Fields of papers citing papers by James N. Jarvis
This network shows the impact of papers produced by James N. Jarvis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James N. Jarvis. The network helps show where James N. Jarvis may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James N. Jarvis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 4 | |
| 4 | 2020 | 17 | |
| 5 | 2020 | 15 | |
| 6 | 2019 | 11 | |
| 7 | 2018 | 29 | |
| 8 | 2018 | 35 | |
| 9 | 2018 | 8 | |
| 10 | 2016 | 21 | |
| 11 | 2015 | 45 | |
| 12 | 2013 | 8 | |
| 13 | 2012 | 11 | |
| 14 | 2009 | 9 | |
| 15 | 2009 | 15 | |
| 16 | 2008 | 40 | |
| 17 | 1999 | 24 | |
| 18 | 1997 | 25 | |
| 19 | Odds on for asthma | 1996 | 4 |
| 20 | 1995 | 15 |
About James N. Jarvis
James N. Jarvis is a scholar working on Hematology, Immunology and Speech and Hearing, having authored 113 papers that have together received 2.0k indexed citations. Recurring topics across this work include Autoimmune and Inflammatory Disorders Research (41 papers), Adolescent and Pediatric Healthcare (17 papers), Systemic Lupus Erythematosus Research (14 papers), Childhood Cancer Survivors' Quality of Life (12 papers), Rheumatoid Arthritis Research and Therapies (12 papers), Lymphoma Diagnosis and Treatment (11 papers), Reproductive System and Pregnancy (9 papers) and Immunodeficiency and Autoimmune Disorders (9 papers). The work is most often cited by research in Hematology (597 citations), Immunology (752 citations) and Speech and Hearing (231 citations). James N. Jarvis has collaborated with scholars based in United States, Japan and India. Frequent co-authors include Kaiyu Jiang, Yanmin Chen, Mark Barton Frank, Michael Centola, John M. Chaney, Larry L. Mullins, Igor Dozmorov, Péter Szodoray, Janelle L. Wagner and Frank Burks. Their work appears in journals such as The Lancet, Nucleic Acids Research and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.